XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Activities    
Net income (loss) attributable to Johnson Controls $ 97 $ 251
Less: Income attributable to noncontrolling interests 73 79
Net income (loss) 170 330
Adjustments to reconcile net income to cash provided (used) by operating activities:    
Depreciation and amortization 467 409
Pension and postretirement benefit income (20) (3)
Pension and postretirement contributions (13) (26)
Equity in earnings of partially-owned affiliates, net of dividends received (102) (55)
Deferred income taxes (400) (168)
Noncash restructuring and impairment charges 253 691
Equity-based compensation 56 61
Other - net (38) (87)
Changes in assets and liabilities, excluding acquisitions and divestitures:    
Accounts receivable (659) (360)
Inventories (228) (493)
Other assets (204) (169)
Restructuring reserves (60) (17)
Accounts payable and accrued liabilities 358 (155)
Accrued income taxes (29) 60
Cash provided (used) by operating activities (449) 18
Investing Activities    
Capital expenditures (225) (255)
Acquisition of businesses, net of cash acquired 1 (89)
Other - net 13 30
Cash used by investing activities (211) (314)
Financing Activities    
Net proceeds from borrowings with maturities less than three months 1,519 1,288
Proceeds from debt 422 316
Repayments of debt (163) (536)
Stock repurchases and retirements (474) (247)
Payment of cash dividends (504) (481)
Employee equity-based compensation withholding taxes (24) (32)
Dividends paid to noncontrolling interests (51) (72)
Other - net (48) 26
Cash provided by financing activities 677 262
Effect of exchange rate changes on cash, cash equivalents and restricted cash 19 8
Increase (decrease) in cash, cash equivalents and restricted cash 36 (26)
Cash, cash equivalents and restricted cash at beginning of period 924 2,066
Cash, cash equivalents and restricted cash at end of period 960 2,040
Less: Restricted cash 117 65
Cash and cash equivalents at end of period $ 843 $ 1,975